Log in to save to my catalogue

5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma

5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_282795

5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma

About this item

Full title

5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma

Publisher

Germany: BioMed Central Ltd

Journal title

Clinical epigenetics, 2016-03, Vol.8 (1), p.31, Article 31

Language

English

Formats

Publication information

Publisher

Germany: BioMed Central Ltd

More information

Scope and Contents

Contents

Primary hyperparathyroidism is characterized by enlarged parathyroid glands due to an adenoma (80-85 %) or multiglandular disease (~15 %) causing hypersecretion of parathyroid hormone (PTH) and generally hypercalcemia. Parathyroid cancer is rare (<1-5 %). The epigenetic mark 5-hydroxymethylcytosine (5hmC) is reduced in various cancers, and this may...

Alternative Titles

Full title

5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_DiVA_org_uu_282795

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_282795

Other Identifiers

ISSN

1868-7075,1868-7083

E-ISSN

1868-7083,1868-7075

DOI

10.1186/s13148-016-0197-2

How to access this item